BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korzenik JR. Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab. Gastroenterol Clin North Am. 2004;33:285-301, ix. [PMID: 15177539 DOI: 10.1016/j.gtc.2004.02.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Kapadia MK, Rubin PAD. The Emerging Use of TNF-?? Inhibitors in Orbital Inflammatory Disease: . International Ophthalmology Clinics 2006;46:165-81. [DOI: 10.1097/00004397-200604620-00014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
2 Ancowitz B, Shah SA. Infusion services in the gastroenterology practice. Gastrointest Endosc Clin N Am 2006;16:727-42. [PMID: 17098619 DOI: 10.1016/j.giec.2006.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Calvano SE, Coyle SM. Experimental human endotoxemia: a model of the systemic inflammatory response syndrome? Surg Infect (Larchmt) 2012;13:293-9. [PMID: 23072275 DOI: 10.1089/sur.2012.155] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
4 Leite MR, Santos SS, Lyra AC, Mota J, Santana GO. Thalidomide induces mucosal healing in Crohn's disease: Case report. World J Gastroenterol 2011; 17(45): 5028-5031 [PMID: 22174554 DOI: 10.3748/wjg.v17.i45.5028] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
5 John AE, Channon KM, Greaves DR. Chemokines, Chemokine Receptors and Atherosclerosis. Chemokines, Chemokine Receptors, and Disease. Elsevier; 2005. pp. 223-53. [DOI: 10.1016/s1063-5823(04)55009-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Grounds MD, Davies M, Torrisi J, Shavlakadze T, White J, Hodgetts S. Silencing TNFalpha activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Cell Tissue Res 2005;320:509-15. [PMID: 15846506 DOI: 10.1007/s00441-005-1102-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
7 Plosker GL, Lyseng-williamson KA. Adalimumab: In Crohn??s Disease. BioDrugs 2007;21:125-32. [DOI: 10.2165/00063030-200721020-00007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
8 Plamondon S, Ng SC, Kamm MA. Thalidomide in luminal and fistulizing Crohn’s disease resistant to standard therapies. Aliment Pharmacol Ther. 2007;25:557-567. [PMID: 17305756 DOI: 10.1111/j.1365-2036.2006.03239.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
9 Park DK, Park HJ. Ethanol extract of Cordyceps militaris grown on germinated soybeans attenuates dextran-sodium-sulfate- (DSS-) induced colitis by suppressing the expression of matrix metalloproteinases and inflammatory mediators. Biomed Res Int. 2013;2013:102918. [PMID: 23841050 DOI: 10.1155/2013/102918] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]